Volume 22, Issue 1 - Medical Writing Education

Implications of clinical trial data sharing for medical writers

Authors: Joseph S. Ross, Harlan M. Krumholz

Abstract

Download the full article

References

1. National Institutes of Health (NIH). Final NIH statement on sharing research data. 2003. Available from: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html
2. Medical Research Council (MRC). MRC policy on research data-sharing. Available from: http://www.mrc.ac.uk/Ourresearch/Ethicsresearchguidance/datasharing/Policy/index.htm
3. Bill and Melinda Gates Foundation. Our commitment to sharing information. Available from: http://www.gatesfoundation.org/global-health/Pages/our-commitment.aspx
4. Hampton T. European drug agency works to improve transparency, but skepticism remains. JAMA 2012;308(9):850–1.
5. Krumholz HM, Ross JS. A model for dissemination and independent analysis of industry data. JAMA 2011;306(14):1593–4.
6. Loder E. Liberating Clinical Trial Data. 2012; Available from: http://blogs.bmj.com/bmj/2012/10/09/elizabeth-loder-liberating-clinical-trial-data/
7. Thomas K. Glaxo opens door to data on research. New York Times, 11 October 2012.
8. Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM. Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Int Med 2009;169(21):1976–85.
9. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 2009;6(9):e1000144.
10. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292.
11. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457–65.
12. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PloS one 2008;3(8):e3081.
13. Gotzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011;12:249.
14. Ross JS, Gross CP, Krumholz HM. Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health 2012;102(1):72–80.
15. Ross JS, Lehman R, Gross CP. The importance of clinical trial data sharing: toward more open science. Circul. Cardiovasc Qual Outcomes 2012;5(2):238–40.
16. DRYAD Available from: http://datadryad.org/
17. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ 2010;340:c181–0.
18. U.S. National Institutes of Health. ClinicalTrials.gov. 2009 Available from: http://www.clinicaltrials.gov/
19. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database–update and key issues. N Engl J Med 2011;364(9):852–60.
20. Institute of Medicine of the National Academies. Sharing clinical research data: a workshop. Available from: http://www.iom.edu/Activities/Research/SharingClinicalResearchData.aspx
21. Hrynaszkiewicz I, Altman DG. Towards agreement on best practice for publishing raw clinical trial data. Trials 2009;10:17.
22. Vickers AJ. Whose data set is it anyway? Sharing raw data from randomized trials. Trials 2006;7:15.